ReviewJournal of the advanced practitioner in oncology2013

Omacetaxine mepesuccinate: a new treatment option for patients with chronic myelogenous leukemia.

Sandra E Kurtin et al.PubMed ↗Full text ↗

No numbers read from the abstract.